Iniziativa
Trials clinico: A Study to Assess Efficacy/Safety of Ladarixin in Type 1 Diabetes Patients With Preserved ß-cell Function at Baseline.
Referente attività: Buzzetti Raffaella
Area di intervento: SALUTE PUBBLICA E BENESSERE
Durata dell’iniziativa: 2020
Trials clinico: A Study to Assess Efficacy/Safety of Ladarixin in Type 1 Diabetes Patients With Preserved ß-cell Function at Baseline.
raffaella.buzzetti@uniroma1.it